Pediatric Cardiology

, Volume 33, Issue 3, pp 379–386 | Cite as

Prevalence and Spectrum Diseases Predisposing to Sudden Cardiac Death: Are They the Same for Both the Athlete and the Nonathlete?

  • Anjan S. BatraEmail author
  • Seshadri Balaji
Review Article


Sudden cardiac death (SCD) is a rare but devastating event among young people. The precise scale of the event remains undefined. This uncommon but catastrophic event usually is proved to be the consequence of varied unsuspected congenital or acquired cardiovascular diseases. Hypertrophic cardiomyopathy and coronary artery anomalies are the two most frequent causes of SCD. Most commonly, SCD resulting from these diseases occurs during or immediately after exercise. This report highlights the prevalence and spectrum of SCD-predisposing diseases and how they are affected by athletic participation. In addition, disease-specific guidelines for sports participation are addressed.


Athlete Congenital coronary artery anomalies Congenital heart disease Hypertrophic cardiomyopathy Myocarditis Sudden cardiac death 


  1. 1.
    Ackerman MJ (2009) State of postmortem genetic testing known as the cardiac channel molecular autopsy in the forensic evaluation of unexplained sudden cardiac death in the young. Pacing Clin Electrophysiol 32:S86–S89PubMedCrossRefGoogle Scholar
  2. 2.
    Basso C, Maron BJ, Corrado D et al (2000) Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 35:1493–1501PubMedCrossRefGoogle Scholar
  3. 3.
    Brucato A (2008) Prevention of congenital heart block in children of SSA-positive mothers. Rheumatology 47:S35–S37CrossRefGoogle Scholar
  4. 4.
    Cheitlin MD, MacGregor J (2009) Congenital anomalies of coronary arteries: role in the pathogenesis of sudden cardiac death. Herz 34:268–279PubMedCrossRefGoogle Scholar
  5. 5.
    Chugh SS, Reinier K, Balaji S, Uy-Evanado A, Vickers C, Mariani R, Gunson K, Jui J (2009) Population-based analysis of sudden death in children: the Oregon sudden unexpected death study. Heart Rhythm 6:1618–1622PubMedCrossRefGoogle Scholar
  6. 6.
    Corrado D, Thiene G, Nava A et al (1990) Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med 39:588–596CrossRefGoogle Scholar
  7. 7.
    Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G (2003) Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 42:1959–1963PubMedCrossRefGoogle Scholar
  8. 8.
    Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G (2006) Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 296:1593–1601PubMedCrossRefGoogle Scholar
  9. 9.
    Day SM (2009) Exercise in hypertrophic cardiomyopathy. J Cardiovasc Transl Res 2:407–414PubMedCrossRefGoogle Scholar
  10. 10.
    Douglas PS, O’Toole ML, Hiller WDB et al (1990) Different effects of prolonged exercise on the right and left ventricles. J Am Coll Cardiol 15:64–69PubMedCrossRefGoogle Scholar
  11. 11.
    Driscoll DJ, Edwards WD (1985) Sudden unexpected death in children and adolescents. J Am Coll Cardiol 5:118B–121BPubMedCrossRefGoogle Scholar
  12. 12.
    Eckart RE, Scoville SL, Campbell CL et al (2004) Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med 141:829–834PubMedGoogle Scholar
  13. 13.
    Edwards CP, Yavari A, Sheppard MN, Sharma S (2010) Anomalous coronary origin: the challenge in preventing exercise-related sudden cardiac death. Br J Sports Med 44:895–897PubMedCrossRefGoogle Scholar
  14. 14.
    Furlanello F, Bertoldi A, Inama G, Fernando F (1995) Catheter ablation in competitive athletes: indication. J Interv Cardiol 8:837–840PubMedCrossRefGoogle Scholar
  15. 15.
    Gollob MH, Redpath CJ, Roberts JD (2011) The short QT syndrome: proposed diagnostic criteria. J Am Coll Cardiol 57:802–812PubMedCrossRefGoogle Scholar
  16. 16.
    Harmon KG, Asif IM, Klossner D, Drezner JA (2011) Incidence of sudden cardiac death in national collegiate athletic association athletes. Circulation 123:1594–1600PubMedCrossRefGoogle Scholar
  17. 17.
    Heidbüchel H, Corrado D, Biffi A et al (2006) Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II. Ventricular arrhythmias, channelopathies, and implantable defibrillators. Eur J Cardiovasc Prev Rehabil 13:676–686PubMedCrossRefGoogle Scholar
  18. 18.
    Heidbüchel H, Panhuyzen-Goedkoop N et al (2006) Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: Part I. Supraventricular arrhythmias and pacemakers. Eur J Cardiovasc Prev Rehabil 13:475–484PubMedCrossRefGoogle Scholar
  19. 19.
    Hirth A, Reybrouck T, Bjarnason-Wehrens B, Lawrenz W, Hoffmann A (2006) Recommendations for participation in competitive and leisure sports in patients with congenital heart disease: a consensus document. Eur J Cardiovasc Prev Rehabil 13:293–299PubMedCrossRefGoogle Scholar
  20. 20.
    Klein GJ, Gula LJ, Krahn AD, Skanes AC, Yee R (2009) WPW pattern in the asymptomatic individual: has anything changed? Circ Arrhythm Electrophysiol 2:97–99PubMedCrossRefGoogle Scholar
  21. 21.
    Levine MC, Klugman D, Teach SJ (2010) Update on myocarditis in children. Curr Opin Pediatr 22:278–283PubMedCrossRefGoogle Scholar
  22. 22.
    Liberthson RR (1996) Sudden death from cardiac causes in children and young adults. N Engl J Med 334:1039–1044PubMedCrossRefGoogle Scholar
  23. 23.
    Maron BJ, Garson A (1994) Arrhythmias and sudden cardiac death in elite athletes. Cardiol Rev 2:26–32CrossRefGoogle Scholar
  24. 24.
    Maron BJ, Mitchell JH (1994) Revised eligibility recommendations for competitive athletes with cardiovascular abnormalities: introduction to Bethesda conference 26. J Am Coll Cardiol 24:848–850PubMedCrossRefGoogle Scholar
  25. 25.
    Maron BJ, Zipes DP (2005) 36th Bethesda conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 45:2–64CrossRefGoogle Scholar
  26. 26.
    Maron BJ, Epstein SE, Roberts WC (1986) Causes of sudden death in the competitive athlete. J Am Coll Cardiol 7:204–214PubMedCrossRefGoogle Scholar
  27. 27.
    Maron BJ, Gardin JM, Flack JM et al (1995) Assessment of the prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4,111 subjects in the CARDIA study. Circulation 92:785–789PubMedGoogle Scholar
  28. 28.
    Maron BJ, Pelliccia A, Spirito R (1995) Cardiac disease in young trained athletes: insights into methods for distinguishing athlete’s heart from structural heart disease with particular emphasis on hypertrophic cardiomyopathy. Circulation 91:1596–1601PubMedGoogle Scholar
  29. 29.
    Maron BJ, Gohman TE, Kyle SB, Estes NA III, Link MS (2002) Clinical profile and spectrum of commotio cordis. JAMA 287:1142–1146PubMedCrossRefGoogle Scholar
  30. 30.
    Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO (2009) Sudden deaths in young competitive athletes: analysis of 1,866 deaths in the United States, 1980–2006. Circulation 119:1085–1092PubMedCrossRefGoogle Scholar
  31. 31.
    Maron BJ, Haas TS, Doerer JJ, Thompson PD, Hodges JS (2009) Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol 104:276–280PubMedCrossRefGoogle Scholar
  32. 32.
    Pelliccia A, Maron BJ, Spataro A et al (1991) The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 324:295–301PubMedCrossRefGoogle Scholar
  33. 33.
    Pelliccia A, Maron BJ, Culaasso F et al (1996) The athlete’s heart in women: echocardiographic characterization of 600 highly trained elite female athletes. JAMA 276:211–215PubMedCrossRefGoogle Scholar
  34. 34.
    Pelliccia A, Fagard R, Bjørnstad HH et al (2005) Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and pericardial diseases of the European Society of Cardiology. Eur Heart J 26:1422–1445PubMedCrossRefGoogle Scholar
  35. 35.
    Pelliccia A, Corrado D, Bjørnstad HH (2006) Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis, and pericarditis. Eur J Cardiovasc Prev Rehabil 13:876–885PubMedCrossRefGoogle Scholar
  36. 36.
    Pelliccia A, Zipes DP, Maron BJ (2008) Bethesda conference #36 and the European Society of Cardiology consensus recommendations revisited: a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 52:1990–1996PubMedCrossRefGoogle Scholar
  37. 37.
    Probst V, Denjoy I, Meregalli PG et al (2007) Clinical aspects and prognosis of Brugada syndrome in children. Circulation 115:2042–2048PubMedCrossRefGoogle Scholar
  38. 38.
    Schwartz PJ (2006) The congenital long QT syndromes from genotype to phenotype: clinical implications. J Intern Med 259:39–47PubMedCrossRefGoogle Scholar
  39. 39.
    Silka MJ, Hardy BG, Menashe VD, Morris CD (1998) A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 32:245–251PubMedCrossRefGoogle Scholar
  40. 40.
    Spirito P, Seidman CE, McKenna SJ et al (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 36:775–785CrossRefGoogle Scholar
  41. 41.
    Stout M (2009) The Marfan syndrome: implications for athletes and their echocardiographic assessment. Echocardiography. 26:1075–1081PubMedCrossRefGoogle Scholar
  42. 42.
    Sy RW, Gollob MH, Klein GJ et al (2011) Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 8(6):864–871Google Scholar
  43. 43.
    Tiso N, Stephan DA, Nava A et al (2001) Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10:189–194PubMedCrossRefGoogle Scholar
  44. 44.
    Wichter T, Hindricks G, Lerch H et al (1994) Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. Circulation 89:667–683PubMedGoogle Scholar
  45. 45.
    Winkler RB, Freed MD, Nadas AS (1980) Exercise-induced ventricular ectopy in children and young adults with complete heart block. Am Heart J 99:87–92PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Division of Pediatric CardiologyChildren’s Hospital of Orange County, University of California at IrvineOrangeUSA
  2. 2.Division of CardiologyOregon Health and Science UniversityPortlandUSA

Personalised recommendations